NO920983L - Fremgangsmaate for behandling av nevrodegenerative tilstander - Google Patents
Fremgangsmaate for behandling av nevrodegenerative tilstanderInfo
- Publication number
- NO920983L NO920983L NO92920983A NO920983A NO920983L NO 920983 L NO920983 L NO 920983L NO 92920983 A NO92920983 A NO 92920983A NO 920983 A NO920983 A NO 920983A NO 920983 L NO920983 L NO 920983L
- Authority
- NO
- Norway
- Prior art keywords
- nevrodegenerative
- procedure
- treatment
- conditions
- nevrodegenerative conditions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Treatment Of Fiber Materials (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40791389A | 1989-09-15 | 1989-09-15 | |
PCT/US1990/005180 WO1991004032A1 (en) | 1989-09-15 | 1990-09-12 | Methods of treating neurodegenerative conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
NO920983L true NO920983L (no) | 1992-03-13 |
NO920983D0 NO920983D0 (no) | 1992-03-13 |
Family
ID=23614067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO1992920983A NO920983D0 (no) | 1989-09-15 | 1992-03-13 | Fremgangsmaate for behandling av nevrodegenerative tilstander |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0491792A4 (no) |
JP (1) | JPH05506842A (no) |
KR (1) | KR920703068A (no) |
AU (1) | AU643235B2 (no) |
NO (1) | NO920983D0 (no) |
WO (1) | WO1991004032A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993003148A2 (en) * | 1991-08-09 | 1993-02-18 | Massachusetts Institute Of Technology | Tau/neurofilament protein kinases pk40 and pk36 |
DK62592D0 (no) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
ES2125285T3 (es) * | 1992-07-31 | 1999-03-01 | Bristol Myers Squibb Co | Derivados inhibidores de la reabsorcion de adenosina de difenil-oxazoles, tiazoles e imidazoles. |
US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
US5780450A (en) * | 1995-11-21 | 1998-07-14 | Alcon Laboratories, Inc. | Use of adenosine uptake inhibitors for treating retinal or optic nerve head damage |
DE19707655A1 (de) * | 1997-02-26 | 1998-08-27 | Hoechst Ag | Kombinationspräparat zur Anwendung bei Demenz |
US6440455B1 (en) * | 1997-09-02 | 2002-08-27 | Children's Medical Center Corporation | Methods for modulating the axonal outgrowth of central nervous system neurons |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4575498A (en) * | 1983-07-21 | 1986-03-11 | Duke University | Method for restoring depleted purine nucleotide pools |
US4912092A (en) * | 1986-03-27 | 1990-03-27 | The Regents Of The University Of California | Methods for increasing extracellular adenosine and for stabilizing mast cells |
-
1990
- 1990-09-12 WO PCT/US1990/005180 patent/WO1991004032A1/en not_active Application Discontinuation
- 1990-09-12 JP JP90513070A patent/JPH05506842A/ja active Pending
- 1990-09-12 AU AU64015/90A patent/AU643235B2/en not_active Ceased
- 1990-09-12 EP EP19900913759 patent/EP0491792A4/en not_active Withdrawn
- 1990-09-12 KR KR1019920700591A patent/KR920703068A/ko not_active Application Discontinuation
-
1992
- 1992-03-13 NO NO1992920983A patent/NO920983D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
AU6401590A (en) | 1991-04-18 |
EP0491792A1 (en) | 1992-07-01 |
EP0491792A4 (en) | 1992-12-02 |
JPH05506842A (ja) | 1993-10-07 |
AU643235B2 (en) | 1993-11-11 |
WO1991004032A1 (en) | 1991-04-04 |
NO920983D0 (no) | 1992-03-13 |
KR920703068A (ko) | 1992-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO934304L (no) | Fremgangsmaate for behandling av fluoralumosilikatglass | |
NO173498C (no) | Analogifremgangsmaate for fremstilling av substituerte 9-amino-tetrahydroakridiner | |
NO902003D0 (no) | Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer. | |
NO901554D0 (no) | Fremgangsmaate for fremstilling av dinatrium-cefodizim. | |
NO921962D0 (no) | Fremgangsmaate til fremstilling av kokevaesker for sulfatmassekoking | |
NO171974C (no) | Fremgangsmaate for fremstilling av nafthalenderivater | |
NO930574L (no) | Fremgangsmaate for fremstilling av desfluran | |
NO921993L (no) | Fremgangsmaate for efterbehandling av amfotaere eller zwitterioniske tensider | |
NO920983D0 (no) | Fremgangsmaate for behandling av nevrodegenerative tilstander | |
NO913117L (no) | Fremgangsmaate for behandling av benoedeleggende sykdommer. | |
NO893890L (no) | Fremgangsmaate for fjerning av sulfider. | |
NO901067L (no) | Fremgangsmaate for fremstilling av tiofener. | |
NO171373C (no) | Fremgangsmaate for fremstilling av biskarbamater | |
NO900969L (no) | Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin. | |
NO901422L (no) | Fremgangsmaate for fremstilling av alfa-glucosidase-inhibitorer. | |
NO903397D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme derivater av protocatechualdehyd. | |
NO884635D0 (no) | Fremgangsmaate for behandling av most. | |
FI943660A0 (fi) | Menetelmä 3-karbonyyliandrostadieeni-17-karboksamidien valmistamiseksi | |
NO920694L (no) | Fremgangsmaate for etterbehandling av tremasse | |
KR890701106A (ko) | 과지혈증의 치료를 위한 옥소퀴나졸린 유도체의 용도 | |
NO174196C (no) | Fremgangsmåte for fremstilling av omega-decenol | |
NO171565C (no) | Fremgangsmaate for behandling av manganslam | |
NO904070D0 (no) | Fremgangsmaate for fremstilling av alkanfenoner. | |
NO902968D0 (no) | Fremgangsmaate for behandling av boreslam. | |
NO930481L (no) | Fremgangsmaate for fremstilling av klormetaner |